These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10539351)

  • 1. Stent prices starting to retreat.
    Hensley S
    Mod Healthc; 1999 Jul; 29(30):34. PubMed ID: 10539351
    [No Abstract]   [Full Text] [Related]  

  • 2. Stent wars. Guidant beats back market leader Johnson & Johnson with new device.
    Hensley S
    Mod Healthc; 1998 Jan; 28(2):49. PubMed ID: 10175911
    [No Abstract]   [Full Text] [Related]  

  • 3. PTCA catheter prices move down.
    Hosp Mater Manage; 2001 Apr; 26(4):1, 11-3. PubMed ID: 11329975
    [No Abstract]   [Full Text] [Related]  

  • 4. As technology races for the stars, so do costs.
    Ford RL
    Hosp Mater Manage; 1996 Aug; 21(8):18. PubMed ID: 10159426
    [No Abstract]   [Full Text] [Related]  

  • 5. Price survey. PTCA prices heading up again.
    Hosp Mater Manage; 2003 Aug; 28(8):1, 12-5. PubMed ID: 12920777
    [No Abstract]   [Full Text] [Related]  

  • 6. Price survey. PTCA prices still moving down.
    Hosp Mater Manage; 2002 Jun; 27(6):1, 12-3. PubMed ID: 12073811
    [No Abstract]   [Full Text] [Related]  

  • 7. A two-step program of competitive bidding and physician feedback to reduce coronary angioplasty equipment costs.
    Vaitkus PT; Senesac DL
    Am J Cardiol; 1996 Oct; 78(7):829-32. PubMed ID: 8857493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing subacute thrombosis.
    Pate G; Webb JG
    J Invasive Cardiol; 2002 Jul; 14(7):369-70. PubMed ID: 12082188
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common sense, dollars and cents, and drug-eluting stents.
    Vaitkus PT
    J Am Coll Cardiol; 2006 Jul; 48(2):268-9. PubMed ID: 16843173
    [No Abstract]   [Full Text] [Related]  

  • 13. Current clinical characteristics and economic impact of subacute stent thrombosis.
    Reynolds MR; Rinaldi MJ; Pinto DS; Cohen DJ
    J Invasive Cardiol; 2002 Jul; 14(7):364-8. PubMed ID: 12082187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
    Odell A; Landelius P; Astrom-Olsson K; Grip L
    Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTCA catheters become less costly.
    Hosp Mater Manage; 1999 Feb; 24(2):1, 12-3. PubMed ID: 10346045
    [No Abstract]   [Full Text] [Related]  

  • 16. eComment: Costs of percutaneous coronary intervention versus coronary artery bypass surgery.
    Almeida RM
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):672. PubMed ID: 19443497
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac relief. Stent prices could drop with FDA approvals ahead.
    Hensley S
    Mod Healthc; 1997 Jul; 27(28):86. PubMed ID: 10168525
    [No Abstract]   [Full Text] [Related]  

  • 18. Could your financial health be heading for heart break?
    Finarelli HJ
    Healthc Financ Manage; 2003 Aug; 57(8):68-72. PubMed ID: 12938623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.